Turning clinical data into market impact

Clinical data - from trial results and real-world evidence to patient outcomes - we work with you to turn data into actionable insights and measurable impact

We bring a unique combination of strong business acumen and deep clinical and scientific expertise.

With 15 years of experience in the pharmaceutical industry, we have worked across medical affairs, commercial teams, market access, clinical studies, and communication of product data to healthcare professionals and payers.

In addition, we bring 20 years of clinical and scientific experience, working directly with patients and advancing research.

What we do - built on experience

We specialize in oncology and hematology, turning clinical data into market insights across the product lifecycle. Backed by strong industry and clinical-scientific expertise, we deliver solutions that tackle the scientific, regulatory, and commercial challenges facing pharma. We know how to communicate clinical data with impact — tailored to industry, clinicians, and payers.

"ZEMA understands both sides of the industry—the pharma companies and the world of physicians—and knows exactly how to bridge the gap between them"

Cathrine Biskopstø Ibsen

Sr. OCE-partner at Novo Nordisk, previously Account Manager at ijovi

Testimonials & Clients

How we can collaborate

We develop a tailored solution for you and your company. You are involved throughout the entire process from start to finish.

Tasks

We can assist with tasks within scientific communication and product support, such as

create the medical-scientific content in a document
create the medical-scientific content in a presentation
identify clinical data of importance for your project
set up and execute an advisory board
medical training of your team
assist with a real-world evidence project

Projects

We provide project support to help you execute the tactical elements of your product strategy within scientific communication and product support, such as

develop the medical-scientific content in documents, applications or presentations
identify key opinion leaders and establish what is needed to position your product in the treatment guideline
set up and execute advisory boards
medical training of your team
support with real-world evidence projects

Retainer agreement

We offer a fixed agreement for ongoing assistance with tasks and projects within oncology and hematology in your company.

You will have advice at your fingertips when needed and the possibility of help throughout the entire period.

Testimonials

Testimonials in full length is given upon request

"Mads Hansen is one of the best colleagues I have worked with in 25 years in the industry. At Amgen and Seagen, he was instrumental in launching new cancer treatments in the Nordic market. Mads excels in understanding the medical, financial, and human aspects of healthcare, and his experience as a Chief Consultant at Rigshospitalet enhances his credibility. His expertise in both public and private healthcare systems makes him a highly valuable asset"

Mads Tang Dalsgaard

Chief Executive Officer at ARCEDI Biotech

"Collaborating with Mads Hansen has been one of my best experiences. He quickly grasped our product's essence and market challenges. Since autumn 2023, we've worked with Mads and ZEMA Pharma Consulting. His deep knowledge, network, and understanding of the Danish healthcare system are invaluable, making him our essential "man on the ground" in Denmark. Mads is professional, calm, and thoughtful, providing well-considered advice and actionable steps forward. For my colleagues needing expertise in Denmark, he is the go-to guy"

Neil Yman

Business Lead Nordic at Exact Sciences

"I worked with Mads on a complex project in hematology, where his extensive experience as a physician and strategic advisor made a significant difference. He excels at explaining complex data in a simple and understandable way and he always meets people at their level. His insights into both the pharma industry and the needs of physicians make him an invaluable partner, creating value for both companies and patients."